31 A 33-year-old woman has thyroid enlargement, palpitations, tremor, and weight loss. She denies visual changes. She is otherwise healthy and is on no medications. She reports a family history of a maternal aunt who had radioiodine therapy and her mother who is on thyroid hormone. Physical examination reveals diffuse and doughy thyromegaly, mild asymmetric exophthalmos with bilateral lagophthalmos, tachycardia, and mild tremor. Extraocular motion is preserved. This patient has a fairly classic presentation for Graves disease with signs and symptoms of hyperthyroidism, diffuse thyroid enlargement, and ophthalmopathy. The family history suggests both hyperthyroidism and hypothyroidism on her mother’s side. Current understanding of autoimmune thyroid disease suggests that Hashimoto thyroiditis and Graves disease are genetically related. Initial workup should focus on biochemical confirmation of the hyperthyroidism and amelioration of symptoms, with further workup focusing on the cause of the hyperthyroidism, which could include Graves, thyroiditis (Hashimoto or viral), or toxic adenoma or toxic multinodular goiter. The treatment and prognosis depend on the cause of the hyperthyroidism. Biochemical diagnosis of hyperthyroidism includes thyroid-stimulating hormone (TSH), tri-iodothyronine (T3), and free thyroxine (T4) levels, with low TSH and high free T3 or free T4 levels being diagnostic. Subclinical hyperthyroidism is associated with low TSH with normal free T3 and free T4 levels. The cause of hyperthyroidism can be evaluated using serum antithyroid antibody testing or with radioiodine uptake and scan. Thyroid ultrasound, especially if coupled with antibody testing, may be an alternative to the radioiodine scan in patients with Graves disease. Elevated anti-TSH receptor antibody levels are diagnostic of Graves disease. Elevated antithyroglobulin or antithyroid peroxidase (TPO) antibodies are consistent with chronic lymphocytic thyroiditis (Hashimoto). In the absence of positive antibody testing, elevated erythrocyte sedimentation rate (>60) is consistent with viral subacute thyroiditis (DeQuervan). Radioiodine uptake and scanning will demonstrate marked elevated 24-hour iodine uptake (>35%) and a diffusely positive scan in Graves. The presence of a cold area within a background of Graves disease suggests a nodule that requires workup to exclude malignancy. Radioiodine uptake will be low (<5–10%) in hyperthyroid patients with thyroiditis. Radioio-dine uptake will be mild to moderately elevated in toxic adenoma or toxic multinodular goiter, with scanning demonstrating a solitary hot nodule or multiple hot nodules with the background thyroid suppressed.
Graves Disease
History
Differential Diagnosis—Key Points
Test Interpretation